Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,695
Total Claims
$1.3M
Drug Cost
811
Beneficiaries
$1,584
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+48%
Cost per patient vs peers
$1,584 vs $1,068 avg
+26%
Brand preference vs peers
11.3% vs 9.0% avg
Brand vs Generic
Brand: 1,310 claims · $1.0M
Generic: 10,249 claims · $253K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 42 | $100K |
| Dulaglutide | 46 | $91K |
| Apixaban | 63 | $67K |
| Empagliflozin | 45 | $64K |
| Sitagliptin Phosphate | 48 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 58 | $50K |
| Dapagliflozin Propanediol | 54 | $48K |
| Semaglutide | 19 | $40K |
| Fluticasone/Umeclidin/Vilanter | 24 | $35K |
| Insulin Detemir | 27 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 12 | $29K |
| Insulin Aspart | 17 | $28K |
| Rivaroxaban | 20 | $22K |
| Sitagliptin Phos/Metformin Hcl | 30 | $21K |
| Insulin Degludec | 20 | $18K |
Prescribing Profile
Patient Profile
73
Avg Age
55%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data